"앞선 의술, 더 큰 사랑의 실천 대한민국 중부권에는 단국대학교병원이 있습니다. 사람을 사랑합니다. 생명을 존중합니다. 최첨단 의료서비스와 세계 수준의 진료 전문화, 그리고 끊임없는 연구활동을 통해 대한민국 중부권 지역 주민들의 건강한 삶을 책임지는 단국대학교병원. 단국대학교병원의 사랑과 인술은 언제나 환자를 향해 있습니다."

During the past decade, Dankook University Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 1 clinical trials were completed, i.e. on average, 5.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dankook University Hospital" #1 sponsor was "Seoul National University Hospital" with 3 trials, followed by "Chonnam National University Hospital" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Seung-Jung Park" with 2 trials sponsored and "Yuhan Corporation" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dankook University Hospital" #1 collaborator was "Abbott" with 2 trials as a collaborator, "Asan Medical Center" with 2 trials as a collaborator, "CardioVascular Research Foundation, Korea" with 2 trials as a collaborator, "Dankook University" with 2 trials as a collaborator and "Hanyang University" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Dankook University Hospital" are "Coronary Artery Disease" (5 trials), "Breast Cancer" (2 trials), "Gastric Cancer" (2 trials), "Hepatitis C Virus" (2 trials) and "Myocardial Infarction" (2 trials). Many other conditions were trialed in "Dankook University Hospital" in a lesser frequency.

Most popular intervention types in "Dankook University Hospital" are "Drug" (12 trials), "Device" (7 trials), "Procedure" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alpine" (1 trials), "Baricitinib" (1 trials), "Biofreedom drug-coated stent" (1 trials), "Biomatrix; Biomatrix Flex; Nobori" (1 trials) and "Clotinab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dankook University Hospital" are 26 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Dankook University Hospital". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Dankook University Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Dankook University Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".